会员体验
专利管家（专利管理）
工作空间（专利管理）
风险监控（情报监控）
数据分析（专利分析）
侵权分析（诉讼无效）
联系我们
交流群
官方交流：
QQ群： 891211   
微信请扫码    >>>
现在联系顾问~
下载
著录项
PDF全文
热词
    • 1. 发明授权
      US5124342A 4-hydroxythiazoles as 5-lipoxygenase inhibitors 失效
    • 4-hydroxythiazoles as 5-lipoxygenase inhibitors
    • US5124342A
    • 1992-06-23
    • US553836
    • 1990-07-18
    • Francis A. J. Kerdesky , James H. Holms , Dee W. Brooks
    • Francis A. J. Kerdesky , James H. Holms , Dee W. Brooks
    • C07D277/20 , A61K31/425 , A61K31/426 , A61K31/44 , A61P1/00 , A61P11/00 , A61P29/00 , A61P37/08 , A61P43/00 , C07D277/34 , C07D277/54 , C07D277/64 , C07D417/04
    • C07D417/04 , C07D277/34 , C07D277/54 , C07D277/64
    • A composition for the inhibition of lipoxygenase enzymes comprising a pharmaceutically acceptable carrier and a compound of the formula: ##STR1## wherein R.sub.1 and R.sub.2 are independently selected from the group consisting of alkyl, alkenyl, cycloalkyl, cycloalkenyl, aryl, arylalkyl, arylalkenyl, reduced heteroaryl, and reduced heteroarylalkyl and substituted derivatives thereof having one or more substituents independently selected from the group consisting of halogen, alkyl, halosubstituted alkyl, aryl, arylalkyl, reduced heteroaryl, arylalkoxy, cyano, nitro, COR.sub.4, SO.sub.2 R.sub.4, NR.sub.5 R.sub.6, OR.sub.6, COCX.sub.1 X.sub.2 NR.sub.6 R.sub.7, CON(OH)R.sub.6, NR.sub.6 COR.sub.4, CR.sub.5 (NH.sub.2)CO.sub.2 R.sub.5, NHCX.sub.1 X.sub.2 CO.sub.2 R.sub.5, N(OH)CONR.sub.5 R.sub.6, N(OH)COR.sub.4, NHCONR.sub.5 R.sub.6, C(NOH)NHOH and CONHNR.sub.5 R.sub.6 ;R.sub.3 is selected from the group consisting of hydrogen, a pharmaceutically acceptable salt, COR.sub.4, COCX.sub.1 X.sub.2 NR.sub.6 R.sub.7, CR.sub.8 R.sub.9 OR.sub.10, CH.sub.2 CR.sub.8 (OR.sub.10)CH.sub.2 OR.sub.11 and SiR.sub.12 R.sub.13 R.sub.14 ;R.sub.4 is selected from the group consisting of hydrogen, alkyl, alkenyl, cycloalkyl, cycloalkenyl, aryl, arylalkyl, reduced heteroaryl, reduced heteroarylalkyl, OR.sub.5, NHCX.sub.1 X.sub.2 CO.sub.2 R.sub.5 and NR.sub.6 R.sub.7 ;R.sub.5 is selected from the group consisting of hydrogen, alkyl, alkenyl, cycloalkyl, aryl, arylalkyl, reduced heteroaryl, and reduced heteroarylalkyl;R.sub.6 and R.sub.7 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, cycloalkyl, aryl, arylalkyl, reduced heteroaryl, reduced heteroarylalkyl and (CH.sub.2).sub.n OR.sub.5 where n is 2-4 and R.sub.5 is as defined above;R.sub.8, R.sub.9, R.sub.10 and R.sub.11 are independently selected from the group consisting of hydrogen, alkyl, aryl, arylalkyl and (CH.sub.2).sub.n OR.sub.5 or at least two of R.sub.8, R.sub.9, R.sub.10 and R.sub.11 together form a ring system containing 5-10 atoms wherein said ring system is carbocyclic, heterocyclic or reduced heterocyclic and R.sub.5 and n are as defined above;R.sub.12, R.sub.13 and R.sub.14 are independently selected from the group consisting of alkyl and aryl; andX.sub.1 and X.sub.2 are independently selected from the group consisting of hydrogen, alkyl, alkenyl, cycloalkyl, aryl, and arylalkyl; and the acid addition salts thereof.
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Global Dossier Espacenet 法律信息 同族专利 专利引用
    • 3. 发明授权
      US5183818A Arylalkylether and arylalkylthioether inhibitors of lipoxygenase enzyme activity 失效
    • Arylalkylether and arylalkylthioether inhibitors of lipoxygenase enzyme activity
    • 芳基烷基醚和芳烷基硫醚抑制剂的脂氧合酶活性
    • US5183818A
    • 1993-02-02
    • US750362
    • 1991-08-27
    • Dee W. Brooks , Andrew O. Stewart , Jonathan G. Martin
    • Dee W. Brooks , Andrew O. Stewart , Jonathan G. Martin
    • C07D307/38 , C07D307/42 , C07D333/16 , C07D333/34 , C07D333/56 , C07D495/04
    • C07D307/42 , C07D307/38 , C07D333/16 , C07D333/34 , C07D333/56 , C07D495/04
    • The present invention provides compounds having the structureY-Het-[Q.sub.1 ]-X-[Q.sub.2 ]-Zwhich inhibit the catalytic action of lipoxygenase enzymes, particularly 5-lipoxygenase, and thereby reduce the biosynthesis of leukotrienes B.sub.4, C.sub.4, D.sub.4, and E.sub.4.In the generic formula given above, X is oxygen or sulfur and Het is a heteroaryl group selected from the group consisting of furyl, thienyl, 2-, 3-, and 4-pyridyl, 2- and 3-benzo[b]furyl, 2- and 3-benzo[b]thienyl and thienothienyl.Y is one or two substituents independently selected from hydrogen, hydroxy, halogen, cyano, alkyl, haloalkyl, alkoxy, alkylthio, alkoxyaryl), alkylthioaryl, arylalkoxy, arylalkylthio, aryloxy, arylthio, alkylamido, cycloalkyl, alkanoyl, alkoxycarbonyl, amino, alkylamino, dialkylamino, and the following groups wherein R, at each occurrence, is independently selected from hydrogen and alkyl of from one to six carbon atoms: --CRROR, --NRC(O)R, --NRC(O)OR, and --C(O)NRR.The group Q.sub.1 is absent or is divalent alkylene of from one to six carbon atoms, and Q.sub.2 is divalent alkylene from from two to ten carbon atoms.The group Z is N(OR.sub.1)COR.sub.2 where R.sub.1 is selected from hydrogen or a pharmaceutically suitable salt. R.sub.2 is selected from hydrogen; alkyl; cycloalkyl; amino; alkylamino, optionally substituted by hydroxyl, halogen, alkoxy or carboxyl; dialkylamino in which the alkyl groups are independently are optionally substituted by hydroxyl, halogen, alkoxy or carboxyl; cycloalkylamino; 2-hydroxyethylamino; N-morpholino; N-thiomorpholino; N-piperazine; N'-alkyl-N-piperazine and cyclopropylmethylamino.
    • 本发明提供具有抑制脂氧合酶，特别是5-脂氧合酶的催化作用的结构为Y-Het- [Q1] -X- [Q2] -Z的化合物，从而减少白三烯B4，C4，D4的生物合成， 和E4。 在上述通式中，X是氧或硫，Het是选自呋喃基，噻吩基，2-，3-和4-吡啶基，2-和3-苯并[b]呋喃基的杂芳基， 2-和3-苯并[b]噻吩基和噻吩并噻吩基。 Y是一个或两个独立地选自氢，羟基，卤素，氰基，烷基，卤代烷基，烷氧基，烷硫基，烷氧基芳基），烷基硫代芳基，芳基烷氧基，芳基烷硫基，芳氧基，芳硫基，烷基酰氨基，环烷基，烷酰基，烷氧基羰基，氨基，烷基氨基， 二烷基氨基和下列基团，其中R 1在每次出现时独立地选自氢和1至6个碳原子的烷基：-CRROR，-NRC（O）R，-NRC（O）OR和-C（O ）NRR。 基团Q1不存在或为1至6个碳原子的二价亚烷基，Q 2为2至10个碳原子的二价亚烷基。 基团Z是N（OR 1）COR 2，其中R 1选自氢或药学上合适的盐。 R2选自氢; 烷基; 环烷基 氨基; 任选被羟基，卤素，烷氧基或羧基取代的烷基氨基; 其中烷基独立的二烷基氨基任选被羟基，卤素，烷氧基或羧基取代; 环烷基氨基; 2-羟基乙基氨基; N-吗啉代; N-硫代吗啉代 N-哌嗪; N'-烷基-N-哌嗪和环丙基甲基氨基。
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Global Dossier Espacenet 法律信息 同族专利 专利引用
    • 7. 发明授权
      US5354865A Phenylmethyl derivatives having lipoxygenase inhibitory activity 失效
    • Phenylmethyl derivatives having lipoxygenase inhibitory activity
    • 具有脂氧合酶抑制活性的苯甲基衍生物
    • US5354865A
    • 1994-10-11
    • US942870
    • 1992-09-10
    • Joseph F. Dellaria , Linda J. Dorn , Dee W. Brooks
    • Joseph F. Dellaria , Linda J. Dorn , Dee W. Brooks
    • C07D305/06 , C07D309/04 , C07D309/06 , C07D309/10 , C07D405/12 , C07D235/26 , C07D215/227 , C07D265/36
    • C07D405/12 , C07D305/06 , C07D309/04 , C07D309/06 , C07D309/10
    • Compounds of the structure ##STR1## where Ar is optionally substituted carbocyclic aryl, 5- or 6-membered heterocyclic aryl, 10-membered bicyclic heterocyclic aryl containing one or two nitrogen atoms, 9- or 10-membered heterocyclic containing one or two nitrogen atoms and optionally containing a further nitrogen or oxygen atom and one oxo or thioxo substituent, benzo[b]furyl, benzo[b]thienyl, A.sub.1 is propynylene, methylene, or a valence bond, X is O, S, SO.sub.2, or NR.sub.2, Y is selected from alkyl, haloalkyl, alkoxy, halogen, and hydrogen, A.sub.2 is selected from ##STR2## and methylene where Z is OR.sub.5 or NHR.sub.5 where R.sub.5 is hydrogen or alkyl, R.sub.1 is hydrogen, alkyl, or OR.sub.5, and m and n are integers having a value of 1 or 2 are potent inhibitors of lipoxygenase enzymes and thus inhibit the biosynthesis of leukotrienes. These compounds are useful in the treatment or amelioration of allergic and inflammatory disease states.
    • 其中Ar是任选取代的碳环芳基，5-或6-元杂环芳基，含有一个或两个氮原子的10元双环杂环芳基，含有一个或两个氮原子的9元或10元杂环的结构化合物 并且任选地含有另外的氮或氧原子和一个氧代或硫代取代基，苯并[b]呋喃基，苯并[b]噻吩基，A 1是亚丙炔基，亚甲基或价键，X是O，S，SO 2或NR 2， Y选自烷基，卤代烷基，烷氧基，卤素和氢，A2选自：其中Z是OR 5或亚甲基，其中R 5是氢或烷基，R 1是氢，烷基或OR 5，和m和n 是具有1或2值的整数是脂氧合酶的有效抑制剂，因此抑制白细胞三烯的生物合成。 这些化合物可用于治疗或改善过敏性和炎性疾病状态。
    • 基本信息 添加关注 加入工作空间 PDF全文 PDF下载 全文下载 相似专利 双屏查看 权利要求书 说明书全文 Global Dossier Espacenet 法律信息 同族专利 专利引用
每页展示10个专利
每页展示10个专利
每页展示20个专利
每页展示50个专利
每页展示100个专利

IPRDB

最新中国发明专利 最新美国发明专利 技术领域 专利库 专利分类库 国际专利分类库

热门服务

会员版试用 API 数据接口 找代理 知嘟嘟专利交易 排行榜 大学排行榜 专利百科

关于我们

平台介绍 战略合作 网站地图

友情链接

知嘟嘟专利交易 国家知识产权局 中国商标网

联系方式


©2019-2023 上海吉码数字技术有限公司 版权所有，并保留所有权利 沪ICP备20016256号-6 沪公网安备31011702005475号